BALTIMORE–(BUSINESS WIRE)–KeraLink International (KLI) today announced the launch of the Great Cornea Challenge and the Cornea Technology Accelerator. These bold initiatives are designed to attract and support innovators and entrepreneurs to help in …
Author: Business Wire
Cincinnati Eye Institute, an EyeCare Partners Practice, Opens New CEI Retina Clinic at The Landings in Blue Ash
CINCINNATI–(BUSINESS WIRE)–EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, today announced the grand opening of its Cincinnati Eye Institute (CEI) Retina Clinic at The Landings in Blue Ash, furthering its comm…
Greg Kunst, CEO of Aurion Biotech, Receives Healthcare Leadership Award from Puget Sound Business Journal
SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that CEO Greg Kunst has won one of the Healthcare Leadership awar…
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution
UPPSALA, Sweden–(BUSINESS WIRE)–Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, and Biotage, a global life sciences company, providing high-quality purifi…
Kubota Vision Announces Agreement with AUROLAB for Development, Manufacturing, Supply, and Distribution License of eyeMO
SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the execution of a…
Kubota Vision Announces Vendor Agreement with IQVIA for eyeMO
SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the execution of a…
NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces its partnership with Woo University to support the education of eyecare professionals on the use of amniotic membranes. A free webinar is being held Thurs…
iHealthScreen Inc. Announces UK Medicines and Healthcare Products Regulatory Agency (MHRA) Certification and registration for iPredict™ – Automated AI System for Early Diagnosis of DR, AMD, and Glaucoma
NEW YORK–(BUSINESS WIRE)– #AI–Automated AI System for Early Diagnosis of Diabetic Retinopathy (DR), Age-Related Macular degeneration (AMD), and Glaucoma, and help prevent blindness
Yolanda Becker, MD Joins LifeGift as Vice President and Chief Medical Officer
HOUSTON–(BUSINESS WIRE)–LifeGift announces Yolanda Becker, MD, FACS, FAST, has joined the team as vice president and chief medical officer.
Horus Pharma Is Strengthening Its International Expansion in Support of Its Growth
NICE, France–(BUSINESS WIRE)–Horus Pharma, an independent French company leading player in ophthalmology, strengthens its international presence with the signature of eight distribution agreements – covering Romania, Portugal, Croatia, Turkey, Algeri…
RIBOMIC Phase I and II Data Published in the Eye: Full TOFU/RAMEN/TEMPURA Trial Results Demonstrate Clinical Proof of Concept of Umedaptanib Pegol in Exudative Age-Related Macular Degeneration (nAMD)
TOKYO–(BUSINESS WIRE)–RIBOMIC Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics (TOKYO:4591), today announced that the Eye has published full results from the phase 1 (SUSHI) and phase 2 (TOFU/RAMEN/TEMPURA) trials ev…
Eye Center of North Florida Announces Winner of Their 13th Annual LASIK Hero Campaign
PANAMA CITY, Fla.–(BUSINESS WIRE)–Eye Center of North Florida announces Cody Hill as the winner of their 13th annual LASIK Hero campaign.
Lilian Zhou Appointed to STAAR Surgical Board of Directors
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment …
Warby Parker Announces Participation in the Morgan Stanley Global Consumer & Retail Conference
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Morgan Stanley Global Consumer & Retail Conference…
Eye Health America Announces Newest Acquisition of Medical, Laser, & Surgical Care of Vision and Eye Disease
VENICE, Fla.–(BUSINESS WIRE)–Eye Health America (EHA) Expands Presence with 23rd Partnership Since 2018
DigitalOptometrics Wins Coveted 2023 EyeVote Award for Telehealth Solutions
LAKE SUCCESS, N.Y.–(BUSINESS WIRE)– #digitaloptometrics–DigitalOptometrics won the 2023 EyeVote Award for Telehealth Solutions, recognized for revolutionizing optometric care.
Rootstock Manufacturing ERP Selected to Improve Visibility for Optical Frame Manufacturer’s Operations
SAN RAMON, Calif.–(BUSINESS WIRE)– #CloudERP–French optical frame manufacturer, J.F. REY, selects Rootstock Manufacturing ERP to support its growing product line and international team.
OliX Pharmaceuticals Announces Positive Safety Data and Preliminary Efficacy Effects in a Phase 1 Trial of OLX10212 for Age-Related Macular Degeneration
SUWON, South Korea–(BUSINESS WIRE)– #AMD–OliX announced positive results from a Phase 1 study of OLX10212 for the treatment of Age-Related Macular Degeneration (AMD).
Harrow Completes Transfer of the TRIESENCE® New Drug Application
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Application (NDA) for TRIESENCE® (triamcinolone acetonide inject…
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced receipt of a Complete…